AF
STOK icon

Allworth Financial’s Stoke Therapeutics STOK Stock Holding History

Allworth Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197 Sell
6
-6
-50% -$193 ﹤0.01% 4960
2026
Q1 		$391 Buy
12
+5
+71% +$164 ﹤0.01% 4794
2025
Q4 		$223 Buy
7
+5
+250% +$150 ﹤0.01% 4690
2025
Q3 		$47 Buy
+2
New +$34 ﹤0.01% 4755

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allworth Financial's STOK Position: Q2 2026 in Review

Allworth Financial reduced its Stoke Therapeutics (STOK) stake by 50% in Q2 2026, selling an estimated $193 and leaving 6 shares worth $197. The position accounts for ﹤0.01% of the portfolio, ranked #4960.

Allworth Financial first reported a position in STOK in Q3 2025 and has held it in 4 quarters since. The position peaked at $391 in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Allworth Financial held 6 shares of Stoke Therapeutics worth $197 as of Q2 2026.
  • Allworth Financial sold 6 Stoke Therapeutics shares in Q2 2026, an estimated $193.
  • Stoke Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4960 holding.
  • Allworth Financial first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Allworth Financial's Stoke Therapeutics position peaked at $391 in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.